Carlos Ortiz-Leyba
Overview
Explore the profile of Carlos Ortiz-Leyba including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
647
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alvarez-Marin R, Lopez-Rojas R, Marquez J, Gomez M, Molina J, Cisneros J, et al.
PLoS One
. 2016 Dec;
11(12):e0168468.
PMID: 27992528
Objectives: This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). Methods:...
2.
Diaz-Martin A, Martinez-Gonzalez M, Ferrer R, Ortiz-Leyba C, Piacentini E, Lopez-Pueyo M, et al.
Crit Care
. 2012 Nov;
16(6):R223.
PMID: 23158399
Introduction: Although early institution of adequate antimicrobial therapy is lifesaving in sepsis patients, optimal antimicrobial strategy has not been established. Moreover, the benefit of combination therapy over monotherapy remains to...
3.
Cisneros J, Ortiz-Leyba C, Lepe J, Obando I, Conde M, Cayuela A, et al.
Enferm Infecc Microbiol Clin
. 2011 Apr;
28 Suppl 4:28-31.
PMID: 21458697
The largest consumption of antimicrobials is concentrated in hospitals and within them, the intensive care units. The quality of antimicrobial use is not optimal, with up to 50% of prescriptions...
4.
Garnacho-Montero J, Diaz-Martin A, Garcia-Cabrera E, Ruiz Perez de Pipaon M, Hernandez-Caballero C, Aznar-Martin J, et al.
Antimicrob Agents Chemother
. 2010 May;
54(8):3149-54.
PMID: 20498325
Previous studies have sought to determine the risk factors associated with candidemia caused by non-albicans Candida spp. or with potentially fluconazole-resistant Candida spp. (C. glabrata and C. krusei). Non-albicans Candida...
5.
Ortiz-Leyba C, Garnacho-Montero J, Cayuela Dominguez A
Crit Care Med
. 2009 Feb;
37(3):1179.
PMID: 19237966
No abstract available.
6.
Garnacho-Montero J, Aldabo-Pallas T, Palomar-Martinez M, Valles J, Almirante B, Garces R, et al.
Intensive Care Med
. 2008 Jul;
34(12):2185-93.
PMID: 18622596
Objective: To assess the risk factors associated with CR-BSI development in critically ill patients with non-tunneled, non-cuffed central venous catheters (CVC) and the prognosis of the episodes of CR-BSI. Design...
7.
Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, Aldabo-Pallas T, Cayuela-Dominguez A, Marquez-Vacaro J, et al.
J Antimicrob Chemother
. 2007 Dec;
61(2):436-41.
PMID: 18056733
Objectives: To determine the attributable mortality and excess length of stay (LOS) associated with the use of inadequate empirical antimicrobial therapy in patients with sepsis at admission to the intensive...
8.
Garnacho-Montero J, Ortiz-Leyba C
Crit Care Med
. 2007 May;
35(6):1626-7.
PMID: 17522542
No abstract available.
9.
Ortiz-Leyba C, Garnacho-Montero J
Crit Care Med
. 2007 Apr;
35(3):988-9.
PMID: 17421113
No abstract available.
10.
Garnacho-Montero J, Aldabo-Pallas T, Garnacho-Montero C, Cayuela A, Jimenez R, Barroso S, et al.
Crit Care
. 2006 Jul;
10(4):R111.
PMID: 16859504
Introduction: Genetic variations may influence clinical outcomes in patients with sepsis. The present study was conducted to evaluate the impact on mortality of three polymorphisms after adjusting for confounding variables,...